NCT00185185View on ClinicalTrials.gov

Olmesartan Medoxomil in Atherosclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

February 28, 2006

Conditions
Essential HypertensionAtherosclerotic Cardiovascular Disease
Interventions
DRUG

Olmesartan medoxomil

DRUG

Atenolol

DRUG

Hydrochlorothiazide

tablets

DRUG

olmesartan medoxomil

tablets

DRUG

atenolol

tablets

Trial Locations (1)

Unknown

Munich

All Listed Sponsors
lead

Sankyo Pharma Gmbh

INDUSTRY

NCT00185185 - Olmesartan Medoxomil in Atherosclerosis | Biotech Hunter | Biotech Hunter